Robert L. Rosiello

2015

In 2015, Robert L. Rosiello earned a total compensation of $60.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$6,000,000
Non-Equity Incentive Plan$712,184
Salary$546,154
Stock Awards$53,126,290
Other$13,770
Total$60,398,398

Rosiello received $53.1M in stock awards, accounting for 87.96% of the total pay in 2015.

Rosiello also received $6M in bonus, $712.2K in non-equity incentive plan, $546.2K in salary and $13.8K in other compensation.

Overall ranking

Ranking

9

out of 13,593
Percentile100th

Robert L. Rosiello's 2015 compensation ranked 9th out of 13,593 executive pay records tracked by us this year.

Rosiello earned more than 99.9% of all executives tracked by us in 2015.

Ranking in industry group

Industry groupDrugs
Ranking

4

out of 1,485
Percentile100th

In the industry group of Drugs, Rosiello's pay ranked 4th out of 1,485 executive pay records tracked by us in 2015.

Rosiello earned more than 99.7% of executives in this group.

Source: SEC filing on April 29, 2016.

Rosiello's colleagues

We found six more compensation records of executives who worked with Robert L. Rosiello at Valeant Pharmaceuticals International in 2015.

2015

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like